Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02391402 · ClinicalTrials.gov registry record · NA
Cognitively Augmented Behavioral Activation for Veterans With Comorbid TBI/PTSD
A NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 2
- Study locations
NCT02391402 is a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 73 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02391402, a NA study of Traumatic Brain Injury and Posttraumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this study is to evaluate the efficacy of Cognitively Augmented Behavioral Activation (CABA), a new hybrid treatment for Veterans diagnosed with comorbid mild Traumatic Brain Injury (mTBI) and posttraumatic stress disorder (PTSD). The study's specific goals are to determine whether: 1) CABA reduces PTSD symptoms in Veterans with mTBI/PTSD, 2) CABA reduces cognitive-related functional impairment in Veterans with mTBI/PTSD, 3) CABA results in improvements in depression symptoms, cognitive functioning, and quality of life in Veterans with mTBI/PTSD; and 4) CABA is an acceptable treatment for Veterans with mTBI/PTSD. The overall goal is to develop an evidence-based manualized treatment for comorbid mTBI/PTSD that can be readily implemented in Veterans Health Administration (VHA) treatment settings.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Cognitively Augmented Behavioral Activation
Study Locations (2)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2015-05-04 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02391402
The ClinicalTrials.gov registry entry for NCT02391402 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (74% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT02391402 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oregon, Washington.
Frequently Asked Questions
What is clinical trial NCT02391402 about?
NCT02391402 is a clinical study titled "Cognitively Augmented Behavioral Activation for Veterans With Comorbid TBI/PTSD". The primary objective of this study is to evaluate the efficacy of Cognitively Augmented Behavioral Activation (CABA), a new hybrid treatment for Veterans diagnosed with comorbid mild Traumatic Brain Injury (mTBI) and posttraumatic stress disorder (PTSD). The study's specific goals are to determine ...
What is the current status of trial NCT02391402?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2015-05-04. Estimated completion is 2023-09-30.
What conditions does trial NCT02391402 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Posttraumatic Stress Disorder.
What interventions are being tested in trial NCT02391402?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Cognitively Augmented Behavioral Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02391402?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02391402 being conducted?
This trial has 2 study locations across Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Community-based Implementation of Online EmReg
RECRUITING · NA
-
Evaluation of the Abbott i-STAT TBI Biomarker Test
RECRUITING · NA
-
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.